NMR and Metabolomics—A Roadmap for the Future is a research paper published in Metabolites (2022). On theSindex it has a DataRank of 0. It has been cited 212 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: AG070257
NIH
Grant: CA243255
NIH
Grant: U2CES030167
NIH
Grant: 1946970
NIH
Grant: R01DK117473
NIH
Grant: MCB-1714556
NIH
Grant: R01GM109046
NIH
Grant: P41GM111135
NIH
Grant: 1660921
NIH
Grant: R01AI148160
NIH
Grant: P20 GM113126
NIH
Grant: 5U24AT010811-02
NIH
Grant: 2021-51181-35860
NIH
Grant: R01AI162321
NIA NIH HHS
Grant: R01 AG070257
NCCIH NIH HHS
Grant: U24 AT010811
NCCIH NIH HHS
Grant: 5U24AT010811-02,
NCI NIH HHS
Grant: R21 CA243255
FWCI
13.12
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Additional file 1 of Metabolomic profiles of intact tissues reflect clinically relevant prostate cancer subtypes
Additional file 1 of Metabolomic profiles of intact tissues reflect clinically relevant prostate cancer subtypes
Additional file 2 of Metabolomic profiles of intact tissues reflect clinically relevant prostate cancer subtypes
Additional file 3 of Metabolomic profiles of intact tissues reflect clinically relevant prostate cancer subtypes
Additional file 3 of Metabolomic profiles of intact tissues reflect clinically relevant prostate cancer subtypes
Additional file 2 of Metabolomic profiles of intact tissues reflect clinically relevant prostate cancer subtypes